Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Nov;83(3):841–847. doi: 10.1111/j.1476-5381.1984.tb16240.x

Differential effects of D600, nifedipine and dantrolene sodium on excitation-secretion coupling and presynaptic beta-adrenoceptor responses in rat atria.

K M Callanan, A K Keenan
PMCID: PMC1987072  PMID: 6095963

Abstract

The stimulation-evoked release of tritium was measured from rat atria labelled with [3H]-noradrenaline. The calcium dependence of evoked release and the facilitation of this release via activation of presynaptic beta-adrenoceptors were examined using D600 (methoxyverapamil), nifedipine and dantrolene sodium. Both D600 and nifedipine at dose levels of 20 and 100 microM inhibited evoked release. Dantrolene (20, 100 microM) reduced release by 25%, the effect being maximal at 20 microM. In the presence of 20 nM isoprenaline, a facilitation of evoked release occurred, which was blocked by 0.1 microM (-)-propranolol. The facilitatory action of isoprenaline was abolished by omission of calcium from the buffer, or by D600 or nifedipine, (100 microM). In contrast, the response to isoprenaline was not modified by dantrolene (20, 100 microM). It is concluded that the evoked release of noradrenaline (NA) utilizes Ca from both intra- and extracellular sources and that isoprenaline increases NA secretion by promoting the depolarization-induced influx of Ca.

Full text

PDF
841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler-Graschinsky E., Langer S. Z. Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol. 1975 Jan;53(1):43–50. doi: 10.1111/j.1476-5381.1975.tb07328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker P. F., Meves H., Ridgway E. B. Effects of manganese and other agents on the calcium uptake that follows depolarization of squid axons. J Physiol. 1973 Jun;231(3):511–526. doi: 10.1113/jphysiol.1973.sp010246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boonyaviroj P., Gutman Y. Acetylcholine and cAMP in adrenal medulla:indirect effect. Naunyn Schmiedebergs Arch Pharmacol. 1977 Apr;297(3):241–243. doi: 10.1007/BF00509267. [DOI] [PubMed] [Google Scholar]
  4. Boullin D. J. The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves. J Physiol. 1967 Mar;189(1):85–99. doi: 10.1113/jphysiol.1967.sp008156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cohen J., Gutman Y. Effects of verapamil, dantrolene and lanthanum on catecholamine release from rat adrenal medulla. Br J Pharmacol. 1979 Apr;65(4):641–645. doi: 10.1111/j.1476-5381.1979.tb07876.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dahlöf C., Ljung B., Ablad B. Pre- and postjunctional beta-adrenoceptor mediated effects on transmitter release and effector response in the isolated rat portal vein. Acta Physiol Scand. 1980 Jan;108(1):39–47. doi: 10.1111/j.1748-1716.1980.tb06498.x. [DOI] [PubMed] [Google Scholar]
  7. Desmedt J. E., Hainaut K. Dantrolene and A13187 ionophore: specific action on calcium channels revealed by the aequorin method. Biochem Pharmacol. 1979 Apr 1;28(7):957–964. doi: 10.1016/0006-2952(79)90286-7. [DOI] [PubMed] [Google Scholar]
  8. Ellis K. O., Carpenter J. F. Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant. Naunyn Schmiedebergs Arch Pharmacol. 1972;275(1):83–94. doi: 10.1007/BF00505069. [DOI] [PubMed] [Google Scholar]
  9. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  10. Galper J. B., Catterall W. A. Inhibition of sodium channels by D600. Mol Pharmacol. 1979 Jan;15(1):174–178. [PubMed] [Google Scholar]
  11. Göthert M., Nawroth P., Neumeyer H. Inhibitory effects of verapamil, prenylamine and D 600 on Ca2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(1):11–19. doi: 10.1007/BF00499869. [DOI] [PubMed] [Google Scholar]
  12. HUKOVIC S., MUSCHOLL E. [Noradrenalin loss from the isolated rabbit heart following sympathetic nerve irritation and its pharmacological alteration]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1962;244:81–96. [PubMed] [Google Scholar]
  13. Högestätt E. D., Andersson K. E., Edvinsson L. Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit. Acta Physiol Scand. 1982 Feb;114(2):283–296. doi: 10.1111/j.1748-1716.1982.tb06984.x. [DOI] [PubMed] [Google Scholar]
  14. Karliner J. S., Motulsky H. J., Dunlap J., Brown J. H., Insel P. A. Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J Cardiovasc Pharmacol. 1982 May-Jun;4(3):515–520. doi: 10.1097/00005344-198205000-00025. [DOI] [PubMed] [Google Scholar]
  15. Kohlhardt M., Bauer B., Krause H., Fleckenstein A. Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors. Pflugers Arch. 1972;335(4):309–322. doi: 10.1007/BF00586221. [DOI] [PubMed] [Google Scholar]
  16. Majewski H., McCulloch M. W., Rand M. J., Story D. F. Adrenaline activation of prejunctional beta-adrenoceptors in guinea-pig atria. Br J Pharmacol. 1980;71(2):435–444. doi: 10.1111/j.1476-5381.1980.tb10956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Majewski H. Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors. J Auton Pharmacol. 1983 Mar;3(1):47–60. doi: 10.1111/j.1474-8673.1983.tb00496.x. [DOI] [PubMed] [Google Scholar]
  18. Majewski H., Rand M. J., Tung L. H. Activation of prejunctional beta-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. Br J Pharmacol. 1981 Jul;73(3):669–679. doi: 10.1111/j.1476-5381.1981.tb16802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proc R Soc Lond B Biol Sci. 1973 Jul 3;183(1073):421–425. doi: 10.1098/rspb.1973.0026. [DOI] [PubMed] [Google Scholar]
  20. Statham H. E., Duncan C. J. Dantrolene and the neuromuscular junction: evidence for intracellular calcium stores. Eur J Pharmacol. 1976 Sep;39(1):141–152. doi: 10.1016/0014-2999(76)90122-9. [DOI] [PubMed] [Google Scholar]
  21. Stj-5aarne L., Brundin J. Dual adreoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by BETA-receptors and inhibitor by alpha-receptors. Acta Physiol Scand. 1975 May;94(1):139–141. doi: 10.1111/j.1748-1716.1975.tb05872.x. [DOI] [PubMed] [Google Scholar]
  22. Trifaró J. M. Common mechanisms of hormone secretion. Annu Rev Pharmacol Toxicol. 1977;17:27–47. doi: 10.1146/annurev.pa.17.040177.000331. [DOI] [PubMed] [Google Scholar]
  23. Triggle D. J., Swamy V. C. Pharmacology of agents that affect calcium. Agonists and antagonists. Chest. 1980 Jul;78(1 Suppl):174–179. [PubMed] [Google Scholar]
  24. Weinstock M., Thoa N. B., Kopin I. J. Beta-adrenoceptors modulate noradrenaline release from axonal sprouts in cultured rat superior cervical ganglia. Eur J Pharmacol. 1978 Feb 1;47(3):297–302. doi: 10.1016/0014-2999(78)90237-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES